Live Support

Safe, effective drug/alcohol treatment

All across this country in small towns, rural areas and cities, alcoholism and drug abuse are destroying the lives of men, women and their families. Where to turn for help? What to do when friends, dignity and perhaps employment are lost?

The answer is Palm Partners Recovery Center. It’s a proven path to getting sober and staying sober.

Palm Partners’ innovative and consistently successful treatment includes: a focus on holistic health, a multi-disciplinary approach, a 12-step recovery program and customized aftercare. Depend on us for help with:

Big Pharma Propaganda: How Drug Companies Feed the Crisis

Big Pharma Propaganda: How Drug Companies Feed the Problem

Author: Justin Mckibben

Overprescribing of powerful prescription medications is just one part of how the current American opioid crisis came to be. While incredibly dangerous synthetic drugs like fentanyl came pouring in from across the globe, the pharmaceutical industry right in our own backyard thrived off of the devastation it was helping create. And as more people became aware of how prescription drugs were contributing to one of the worst drug epidemics in the country’s history, Big Pharma has come under fire for a number of things over the years. To name a few, we’ve seen arguments against drug companies for:

With recent reports, such as the explosive piece of 60 Minutes last month, we have also been exposed to the corruption, greed and a disregard for the well-being of the consumer.

The Big Pharma propaganda machine has paid out countless dollars for criminal and civil settlements over the years. Now even state officials are resorting to lawsuits against drug manufacturers in the fight against the ongoing opioid crisis.

So how did all this happen? How deep does the Big Pharma propaganda go? Some of this you might already know, but some of it might actually surprise you.

Prescription Politics

In case you didn’t know, the pharmaceuticals and health products industry spends the most money on lobbying politicians. And not even by a little.

  • Big Pharma and Health Products spent $3,714,580,815

That means that Big Pharma spends:

  • $1,134,783,913 more than 2nd place- Insurance Companies
  • $1,717,237,691 more than Oil/Gas Companies

The pharmaceutical industry, including dealers of medical products and nutritional/dietary supplements, is consistently a top contributor more to federal campaigns than any other industry.

In essence, drug companies spend big money on politics.

Whether we can always see it or not, this kind of financial incentive is more than likely playing into our current work on policy. For example, moves to pass legislation earlier this year were called into question by one source who pointed out 13 senators who were trying to push through a bill that would benefit the health insurance and pharmaceutical companies were receiving hundreds of thousands of dollars in contributions from these companies between 2010 and 2016, including:

  • Utah Republican Senator Orrin Hatch led the way with more than $471,000
  • Kentucky Republican Senator Mitch McConnell with over $433,00 in donations

FUN FACT- Many lobbyists working on behalf of Big Pharma companies have previously held government jobs.

Information Manipulation

Truthfully, drug companies spend several years before a drug even makes it to the market on planning a strategy for selling it to you. Part of that strategy is proving drugs have value for treatment. However, according to some industry insiders, a lot of the time there is not enough comprehensive data to prove that value.

What you might also find surprising is that some of the earliest information drug companies have published about their products aren’t actually from credible sources. Ad agencies will hire writers to produce articles on behalf of the drug maker highlighting benefits of a drug. But the data is often cherry-picked and incomplete.

These articles are then sold to the public as ‘scientific’ because they are printed and published by some of the biggest scientific and medical publications, such as the New England Journal of Medicine. Those articles are then picked up by television and other news sources.

So essentially, drug companies often team up with marketing companies to fool not just doctors, but the public into thinking their product provides something that has yet to be proven. Big Pharma propaganda corrupts the research into their drugs and makes people believe their products are safer and more effective than they are.

For more important information on the dangers of prescription drugs, download our FREE E-BOOK “Big Secrets of Big Pharma: Why They Secretly Hope You Get Hooked”

DOWNLOAD FREE E-BOOK

Big Pharma’s Billions in Ads

It isn’t just behind the scenes that Big Pharma propaganda takes place. Drug makers spend around $21 billion a year just to pedal products through advertising. One big problem for Americans is that many of their promotional techniques have been called out for being false advertising or misleading, to say the least.

  • 2015, the industry spent a record-breaking $5.4 billion of direct-to-consumer ads alone.
  • The same year, Americans spent over $450 billion on prescription drugs.

Some sources indicate there are about 80 drug advertisements per hour. While drug companies want people to think it is raising awareness, it is most definitely a commercial to sell you something.

Many pharma companies even have deep financial ties to medical communication companies (MCC) like WebMD or Medscape. This is just one more way they can influence physicians and consumers without people realizing the drug makers are funding the information.

Doctors Recruiting Doctors

But the drug makers don’t stop with recruiting politicians to support them. They also utilize doctors to help them push their products. The main target audience in most of the campaigns pushed by Big Pharma propaganda is not necessarily the consumer as much as it is the person who writes the prescriptions.

Drug companies giving kickbacks to doctors is nothing new.

So drugmakers create an advisory board, where some of the most successful and well-respected doctors are put on the payroll with huge payoffs to help drug companies design a marketing campaign that will help promote the drugs to other doctors. Once these doctors have helped highlight the best ways to convince other physicians these drugs work, they themselves validate the drug in a way that encourages other doctors to prescribe the drug.

Drugs to Treat Drugs

A while back there was an ad that ran during the Superbowl that caught the attention of a lot of people. It was an ad selling an anti-constipation drug for those so dependent on prescription opioids that they were suffering from constipation as a side effect.

This is another huge problem with how drugs are marketed to us… in tandem.

Instead of suggesting an alternative treatment, drug companies want to give you more drugs to combat the effects of other drugs. Doctors will often prescribe a second medication for no other purpose than to treat the effects of the first medication. Big Pharma propaganda can literally sell you the illness and the medicine in the same marketing campaign. A 2012 study published in the journal Annals of Family Medicine describes this as “prescribing cascade”.The study indicates that the practice of using drugs to treat problems with other drugs is a key component to the heavy reliance on pharmaceuticals in healthcare.

Another devastating way this has taken place is when doctors prescribe powerfully and potentially habit-forming narcotic medications to combat illicit drug use and substance use disorder. Heroin addicts are being treated with other strong narcotics, which can actually have their own withdrawal symptoms and side effects. They even highjacked the opioid overdose antidote and several makers gouged the prices to offensive new heights during the rise of the opioid epidemic.

Drug Companies Abuse of Americans

Now let us be fair; modern medicine does provide us with some life-saving resources that can be paramount to the health and wellness of our population. Thanks to great strides in medicine doctors are able to treat some conditions or illnesses that were once thought of as a death sentence. Today, we have some of the greatest opportunities to receive quality care with innovative and well-researched treatments.

However, the fact remains that drug companies have been caught red-handed more than a few times misrepresenting their products, hiding the side-effects, falsely advertising their benefits and even recently some huge names in pharmaceuticals have been accused of bribery and racketeering to sell potent and extremely dangerous drugs.

So, what can be done?

  1. We can take a closer look at how Big Pharma propaganda influences or elected representatives and their decisions on policy.
  2. We can pay attention to how the information provided by pharmaceutical companies or marketers is not always as reliable as it may seem.
  3. Look into excessive advertising for potent drugs
  4. Do more to combat drug makers from paying doctors to promote their drugs to other doctors.
  5. Pursue other forms of treatment that don’t require expensive and powerful drugs.

When it comes to drug abuse, maybe we shouldn’t let the drug companies continue to make massive profits from a problem they have a large hand in creating. There needs to be more commitment to finding alternative treatments that don’t rely so heavily on drugs in order to help people get healthy.

Holistic drug addiction treatment is a unique and effective way of helping people struggling with substance use disorder. The fact that powerful drugs help cause addiction, let us not forget the value of offering healing options that don’t require more drugs. Building a strong foundation with personalized therapy and innovative treatment opportunities helps thousands of people all over the nation overcome addiction. Palm Partners Recovery Center is committed to providing quality care for those dealing with drug abuse, whether it is illicit drugs or prescription drug dependence. If you or someone you love is struggling, please call toll-free now. We want to help.   

CALL NOW 1-800-951-6135

Tom Marino Proud of Law Critics Say Made Opioid Epidemic Worse

Tom Marino Proud of Law Critics Say Made Opioid Epidemic Worse

Author: Justin Mckibben

Earlier this week we talked about a story that shook things up in politics as a former DEA agent threw some serious accusations at the Big Pharma industry, Congress and a number of key officials for their involvement in policies some believe helped create the enduring opioid crisis in America. Among those accused of tipping the scales in favor of Big Pharma and stripping power away from those charged with regulating the industry was Republican Representative Tom Marino.

Of course, we know that Tom Marino was President Donald Trump’s top nominee to be the nation’s drug czar.

Now, after withdrawing from the nomination to head the White House Office of National Drug Control Policy, Tom Marino says he is proud of his role in writing a 2016 law that many critics say paved the way for the current epidemic.

The Tom Marino Factor

What kind of role did Tom Marino have in the creation of the Ensuring Patient Access and Effective Drug Enforcement Act? Why is it that so many are up in arms about the bill in the first place?

To recap- Pennsylvania Congressman Tom Marino and Congresswoman Marsha Blackburn of Tennessee introduced a bill to the House. It was advertised to officials as a way to ensure that patients had access to the pain medication they needed. In a statement released by Marino’s office, he claims the law would help “facilitate a balanced solution” by ensuring access to certain medications while allowing the Drug Enforcement Administration to prevent the sale and abuse of prescription drugs.

In essence, Tom Marino was supposedly pushing for a way to let pain management patients still get the useful medications they needed, without impeding on the process of curbing abuse.

But that isn’t how everyone sees it, especially after the 60 Minutes story.

Why it Matters

According to the opposition, the bill ultimately did little else besides weaken the DEA and the government’s authority to stop companies from distributing opioids in suspicious shipments.

For years prior to the passage of the “Marino Bill” some big-time drug distributors were getting fined thousands of dollars for repeatedly ignoring DEA warnings to shut down suspicious sales of hundreds of millions of pills. These companies were racking up billions of dollars in sales while turning a blind eye to obnoxious overprescribing of dangerous drugs.

Back then the DEA was able to immediately prevent drugs from reaching the street by freezing suspicious shipments. If the DEA judged that the drugs posed an “imminent danger” to a community, they could take action to prevent the flood of powerful narcotic medications from overwhelming the area.

However, the Tom Marino bill is argued to make it virtually impossible for the DEA to freeze suspicious narcotic shipments from the companies. Now, the agency is required to demonstrate that a drug distributor’s actions represent “a substantial likelihood of an immediate threat,” which officials say is far more difficult criteria to meet. The report against the Tom Marino bill even cited internal DEA and Justice Department documents and an independent assessment by the DEA’s chief administrative law judge.

The DEA even fought the bill, according to people within the agency, but in 2015 the law gained momentum again when the Justice Department named a new chief of the DEA- Chuck Rosenberg. After some reluctance, the report on 60 Minutes that included exclusive insight from Joseph T. Rannazzisi states the DEA ultimately took a deal they did not want.

Champion for Big Pharma

Marino disputed that, calling the reports “false accusations and unfair reporting.”

Tom Marino spent years pushing versions of this bill through Congress. He argued that it was to put an overly-aggressive DEA in check and protect drug companies from what he believed was unfair or misguided federal interference. In other words, he spent a lot of time fighting for Big Pharma’s ability to send millions of pills to communities that didn’t have half the population to justify them. All because the DEA was being aggressive?

The irony here is that the same people who pushed so hard for drug distributors ability to traffic obscene among of pills without the pesky DEA would probably be the same people demanding mandatory minimums for low-level drug offenders on the streets.

And again, many are still suspicious of those involved in pushing for this kind of legislation because of their connections to Big Pharma industry. The Post reports that the drug industry worked behind the scenes with lobbyists and key members of Congress, including Tom Marino.

Some reports indicate the Big Pharma industry poured more than a million dollars into election campaigns, including Marino’s, who received nearly $100,000 in campaign contributions from political action committees supporting the drug industry.

Utah Republican Senator Orrin Hatch calls the report “complete baloney” after it gained serious momentum earlier in the week.

Why are we not surprised? Because Hatch himself has received hundreds of thousands in donations from Big Pharma companies and health contributors over the years.

Holding Big Pharma accountable for their contribution to the opioid epidemic has become an increasingly popular cause. Lawyers and politicians at all levels have been pushing to put a spotlight on the shady side of the pharmaceutical industry. Now it seems that spotlight may extend more and more to exposing the politics that allow these issues to spread.

Another crucial element to putting an end to the opioid epidemic is providing safe and effective treatment for those who need help the most. A lot of people are still out there suffering because of prescription drug abuse or other dangerous substances. But we want to help. If you or someone you love is struggling, please call toll-free now.

CALL NOW 1-800-951-6135

Ex-DEA Agent Blames Congress and Big Pharma for Opioid Crisis

Ex-DEA Agent Blames Congress and Big Pharma for Opioid Crisis

Author: Justin Mckibben

Ever since the true nature of the opioid epidemic in America began to come to light, and people started to see the gravity of its impact in communities across the country, there have been plenty of efforts to find out how we ever got this far. We continue to ask who should be held accountable. Was it the black market drug trade? Was it the synthetic opioids coming from overseas? How did it get this bad?

Just this past week 60 Minutes and The Washington Post joined forces to interview Joe Rannazzisi, who is said to be the most important whistleblower ever on 60 Minutes.

Joe Rannazzisi is a former agent of the Drug Enforcement Administration (DEA) who ran the Office of Diversion Control; the department in charge of regulating and investigating the pharmaceutical industry. He is a former DEA deputy assistant administrator with a law degree, and a pharmacy degree, who believes the great injustice done to the American people cannot go overlooked.

Bad Business with Big Pharma

Through this inside look with Rannazzisi, he implicates Big Pharma drug makers in willingly distributed hundreds of millions of drugs to rogue pharmacies and pain-clinics-turned-pill-mills for over two decades.

Rannazzisi believes that the Big Pharma companies, some even multi-billion, Fortune 500 companies, have contributed to the problem by ignoring the truth; that powerful prescription pain medications were being diverted from doctors, clinics and pharmacies for illicit use. In the interview, Rannazzisi calls out a number of key drug makers, including:

He also calls out the three largest drug distributors:

  • Cardinal Health
  • McKesson
  • AmerisourceBergen

Saying they control probably 85%- 90% of drugs “going downstream.”

In fact, Rannazzisi said the way pain clinics seemed to pop up overnight all over the country made the whole crack-cocaine epidemic look like nothing, saying he had never seen anything like it, adding:

“These weren’t kids slinging crack on the corner. These were professionals who were doing it. They were just drug dealers in lab coats.”

Rannazzisi says after prosecuting pain doctors and pharmacists didn’t seem to put a real dent in the problem, he knew he had to work his way up; they went after distributors.

While drug distributors tried to defend themselves saying it was all on the doctors for over-prescribing medications, Rannazzisi says they know exactly how many pills are being sent out. Under the Controlled Substances Act, these distributors are required by law to report and stop what the DEA refers to as “suspicious orders”.

So what might “suspicious orders” look like? Probably something lie unusually large and/or frequent shipments of opioids being made to a location. Kind of like what was happening all over the nation for years and years.

For example, just one pharmacy in Kermit, West Virginia ordered 9 million hydrocodone pills in just over 2 years. That’s for a town of only 392 people. That’s over 11,479 pills a person each year! Almost 1,000 pills a month! From only one of the town’s pharmacies.

DEA investigators say many drug distributors ignored the DEA requirements and shipped anyway.

DEA Fighting Back

Rannazzisi wasn’t the only DEA agent to speak up about Big Pharma’s bad business. Several other DEA veterans say they saw thousands of suspicious orders and tried to fight the growing problem. Others said they tried on multiple occasions to get these companies to fix the issue, but they did nothing.

Eventually, in 2008 the DEA was able to hit some distributors with hefty fines for filing hundreds of suspicious orders, including:

  • $13.2 million fine against the country’s largest drug distributor, McKesson
  • $34 million fine against second-largest distributor, Cardinal Health

The fines for drug distributors over the last 7 years add up to around $341 million.

The High Rollers

In 2011, Cardinal Health attorneys called Rannazzisi’s boss at the Justice Department, who called Rannazzisi and pressed for an explanation for his policies. Rannazzisi believes that even after they had gone after small companies hundreds of times before, as soon as they went after the Fortune 500 drug makers, their power and influence started getting in his way.

Rannazzisi says that with these massive Big Pharma empires there was now money and influence being used to pressure top lawyers at the DEA to pursue a softer approach on penalizing drug distributors who broke the rules.

Former DEA attorney Jonathan Novak noticed that shocking shift in the way these kinds of cases were handled. Stating:

“These were not cases where it was black — where it was grey… These were cases where the evidence was crystal clear that there was wrongdoing going on.”

But suddenly the higher ups started to demand more and more evidence to stall the system. Fewer cases against Big Pharma companies were being approved, and road-blocks from Novak’s bosses seemed to pop up everywhere.

Novak also said he saw a huge migration of DEA lawyers switching sides to defend the drug industry in higher paying positions.

Taking it to Congress

While drug distributors started successfully stalling the progress of cases against them from the DEA, they also began to lobby Congress to get legislation that would destroy the DEA’s power over them.

Then one day Pennsylvania Congressman Tom Marino and Congresswoman Marsha Blackburn of Tennessee introduced a bill to the House that was promoted as a way to ensure that patients had access to the pain medication they needed. However, Jonathan Novak, who worked in the DEA’s legal office, claims that what the bill really did was strip the agency of its ability to immediately freeze suspicious shipments of prescription narcotics to keep drugs off U.S. streets.

The bill’s author… Linden Barber, a former employee of the DEA.

Congressman Tom Marino, along with Congresswoman Blackburn, later wrote the inspector general for the Justice Department, demanding that Rannazzisi be investigated for trying to quote “intimidate the United States Congress.” Even though this went nowhere, Rannazzisi was stripped of his responsibilities soon after.

Some former DEA agents believe that the Big Pharma industry not only used lobbying groups to donate money to politicians to get laws passed in their favor, but also to try and push Joe Rannazzisi out of his office.

In the end, the DEA signed off on the final version of the “Marino bill.” A senior DEA representative claiming that even though they fought to stop it, growing pressure from Congress and industry lobbyists forced them into a deal it did not want.

The bill was presented to the Senate in March of 2016.

Majority Leader Mitch McConnell introduced the legislation in the Senate.

It passed by unanimous consent with no objections and no recorded votes.

It passed the House the same way, and President Obama signed it into law.

Where Are We Now?

This whole thing reminds you of the saying- if you can’t beat em, join em.

It would seem that’s exactly what a lot of DEA agents did after fighting a losing battle against powerful Big Pharma companies.

Since it all began, the pharmaceutical industry and law firms that represent them have hired at least 46 investigators, attorneys, and supervisors from the DEA, including 32 directly from the division that regulates the drug industry.

Remember that guy Linden Barber, who authored the bill that many say stripped the DEA of the power to go after Big Pharma companies? Well 3 months ago Cardinal Health, that second-largest drug distributor we were talking about that went after Rannazzisi through his boss, hired Linden Barber as the senior vice president!

Other former DEA agents and lawyers have gone on to take up so pretty prestigious positions working for drug companies, or law firms and other organizations working in the pharmaceutical industries best interest.

Joe Rannazzisi now consults with state attorneys general who have filed suit against distributors for their role in the opioid crisis.

Oh… and let us not forget Congressman Marino, who was just nominated to become President Trump’s new drug czar.

Remarkably, there are a lot of instances of people in the DEA being influenced by pharmaceutical companies and lobbyists to stand up for drug companies instead of the tens-of-thousands of Americans dying from opioids each year. In many of these instances, the individual’s go on to get high-earning jobs defending the interests of the Big Pharma industry.

So is it a made-up conspiracy? Or are pharmaceutical companies buying their way out of trouble at every turn and pushing out people like Rannazzisi who stand up to them? Is it really that hard to believe when you connect the dots?

With an ongoing opioid epidemic doing major damage to the country, we have to acknowledge everything that has contributed to this issue. Even if we set aside the idea of placing blame, we cannot prevent it from getting worse or happening again if we don’t acknowledge what helped cause it. Every drug company, policy maker, pharmacy, crooked doctor and individual should be accountable to taking action to make things better. It starts with accepting the issue and building a foundation to recover. If you or someone you love is struggling, please call toll-free now. We want to help.

CALL NOW 1-800-951-6135

Global Commission on Drug Policy Suggests Harm Reduction and Decriminalization

Global Commission on Drug Policy Suggests Harm Reduction and Decriminalization

Author: Justin Mckibben

The Global Commission on Drug Policy (GCDP) is an international institution of global leaders and intellectuals working to help study and inform initiatives on addressing drug use all around the world. This think tank offers recommendations concerning drug use and its consequences for societies across the globe.

The GCDP consists of members from various nations, including but not limited to:

  • The United States of America
  • The United Kingdom
  • India
  • France
  • Greece
  • Spain
  • Mexico
  • Nigeria
  • Canada

Former U.S. President Jimmy Carter wrote an op-ed in The New York Times explicitly endorsing the recommendations of the Global Commission on Drug Policy, and the group has released various reports over the years focusing on the efforts to curb the spread of drug abuse.

Recently the GCDP released a position report on the North American opioid epidemic. In this report, the commission issues recommendations that appear to endorse the expansion of harm reduction techniques to battle the ongoing crisis.

The Turning Point for America

According to the GCDP’s new report, North America is at a turning point in the way that drug addiction is viewed. This is not too much of a surprise, considering now more than ever there has been a push for a more compassionate perspective on drug use and addiction. America now finds itself in a unique position where the stigma that has so long been attached to addiction is starting to be abandoned, and more progressive action is being taken.

Now the Global Commission on Drug Policy believes national policymakers should take advantage of this unique opportunity to reduce opioid-related deaths through harm reduction. In the report the authors state:

“While in recent years media and politicians have been more open to viewing addiction as a public health problem, leadership is needed to turn this into an urgent and commensurate response to the crisis,”

One way that the Global Commission on Drug Policy ideals clashes with that of the Trump administration, currently steering drug policy in America is that the GCDP does not endorse the old policies of the War on Drugs.

GCDP vs War on Drugs

Back in June of 2011, the GCDP stated:

“The global war on drugs has failed, with devastating consequences for individuals and societies around the world.”

Again, this recent report echoes that sentiment, saying that attempting to cut off the opioid supply is not the answer. The new report notes how this approach has been tried before, as the first reactions to the opioid epidemic were to limit prescriptions and to introduce pills that were harder to manipulate.

The report goes on to note that this response drove people to use cheaper and often much more potent street drugs instead of prescription pills. Fentanyl is one of the worst synthetic opioids to contribute to the outbreak of overdoses and deaths across the country.

The Global Commission on Drug Policy says cutting off the supply of opioids into the country cannot be effectively executed until after supportive measures are put in place. This means supporting not only both people battling addiction but also people with chronic pain. The report insists:

“The aim is to achieve the right balance in regulation to provide effective and adequate pain care, while minimizing opportunities for misuse of these medications.”

To reduce the harmful impacts of opioids, the commission calling for the acceptance and implementation of harm reduction strategies.

The Global Commission on Drug Policy Suggests Harm Reduction

So if they are saying that the War on Drugs did not work, and neither will bulking up borders, then what will?

Well, according to the GCDP, harm reduction is the right move. The new report calls on American lawmakers to promote programs like:

  • Naloxone Distribution and Training

As the opioid overdose antidote, Naloxone is an invaluable tool to have in the fight against the opioid epidemic in America, but the price for the drug continued to skyrocket as the epidemic got worse. Making it more available could give access to and train people with life-saving medication to thousands or even millions more.

Safe locations where IV drug users can trade old, contaminated needles for new, sterile needles to help prevent the spread of blood-borne illness like HIV.

Facilities where drug users can go to use their drugs with sterile equipment safely, reducing the number of overdose deaths by providing a place free of punishment for them to use with medical emergency resources on site.

  • Drug Checking

These kinds of programs would allow for users to check their drugs for the presence of any unknown substances it may have been diluted with. For example, most fentanyl users do not know they are using fentanyl.

Decriminalizing Drugs in America

In another aspect of the report, GCDP also makes a much more revolutionary and more radical suggestion that many may consider qualifying as harm reduction: decriminalization.

The report states:

“The Global Commission on Drug Policy also calls for the elimination of illicit drug markets by carefully regulating different drugs according to their potential harms. The most effective way to reduce the extensive harms of the global drug prohibition regime and advance the goals of public health and safety is to get drugs under control through responsible legal regulation.”

With this philosophy in mind, the GCDP made two more drastic recommendations:

  • End the criminalization and incarceration of people who use drugs nation-wide in Canada and the United States.
  • Allow and promote pilot projects for the responsible legal regulation of currently illicit drugs including opioids.

The idea is that by decriminalizing drugs, they can bypass criminal organizations and ultimately replace the current black market.

“Do not pursue such offenses so that people in need of health and social services can access them freely, easily, and without fear of legal coercion,”

We have begun to see a watered-down variation of this kind of strategy with many Police Assisted Addiction and Recovery Initiative (PAARI) programs, where law enforcement is helping addicts get into treatment instead of arresting them when they ask for help.

Better Treatment Research

The report insists that more research is necessary in a few critical areas in order the effectively address the opioid crisis and the overall drug problem in America.

One of the key points of research the GCDP proposes is for finding the most effective treatments for addiction, specifically to prescription opioids. In addition, the report shows support for medication-assisted treatment (MAT) and opioid substitution therapy (OST) as a means to preserve life to assist in the recovery process. While these programs are met with some of the same contentions as safe injection sites or decriminalization, the commission seems adamant about using harm reduction to keep people alive long enough to get better.

Michel Kazatchkine, a doctor and commission member, said in a recent interview:

“Repression is harmful. Wherever repressive policies are in place, people will not be in the best condition to access services.”

While he and other commission members are in no way naïve to the fact there is no way decriminalization will happen at the federal level soon in the U.S., they remain hopeful that states or cities will make decisions which don’t require federal approval, or for which they are willing to enter to fight with the federal process.

Overall, the hope of the GCDP is that these suggestions, coming from a group of world leaders fully invested in understanding the issue, will convince American and Canadian lawmakers to take a progressive approach to the crisis.

What could some of these changes mean for those trying to recover from opioid abuse? How could some of these ideas change the way addiction treatment operates within America?

One thing is for certain, in fighting opioid addiction, whether as a society, as a family or as an individual, there needs to be compassion and action. It takes courage and it takes a degree of uncertainty. But with the right resources, there is hope for a greater future. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now.

CALL NOW 1-800-951-6135

Florida Governor Pushing for 3 Day Limit on Prescription Opioids

Florida Governor Pushing for 3 Day Limit on Prescription Opioids

While the entire country has been impacted by this ongoing issue, more options for prevention and treatment have become paramount to changing the tides. Just this week Rick Scott, the governor of the state of Florida, proposed a strategy for fighting the opioid epidemic that has gained a lot of attention. Scott has decided to ask local lawmakers to impose a three-day limit on opioid prescriptions during the upcoming legislative session. This latest development is one new piece of recent initiatives to combat the opioid crisis.

Florida Governor Opioid Initiatives

During two press conferences on Tuesday, the Florida Governor announced a pushback on an abundance of opioid prescriptions, while also introducing other ideas for fighting addiction.

One of the initiatives Rick Scott is pushing is to require all health-care professionals who prescribe controlled substances to participate in the Florida Prescription Drug Monitoring Program, also known as the PDMP. This database involves health-care professionals to report important information on patients receiving powerful narcotic medications, including:

  • Name of the doctor
  • Patient name
  • Prescription information after the prescription is filled

But this is not the last of Florida Governor Scott’s opioid initiatives. His office also plans to seek additional reforms such as:

  • Fight unlicensed pain management clinics
  • Requiring education on responsible opioid prescribing
  • Creating more opportunities for federal grants

Scott apparently plans to put some more investments toward helping those already struggling. He is also pushing for more than $50 million for services including:

Part of this initiative is also boosting up the budget of the Florida Violent Crime and Drug Control Council.

At the moment the finer details of the Florida Governor’s proposals are not yet available. However, what it does tell us is that Scott is not ignoring the contribution Big Pharma makes in this current crisis. What we can tell from this outline is that Rick Scott says he is aiming to address prescription opioid pain medication, recognizing it as a key source of the growing problem.

Why 3 Days?

It has been reported time and time again that we should be paying attention to how powerful opioid medications impact rising addiction rates. Now the Centers for Disease Control and Prevention (CDC) has released a recent study showing how quickly someone could get hooked on these kinds of drugs. In this study it is shown:

  • After three days of use, about 6% of patients were still using opioids a year later.
  • Five days into use, about 10% of patients were still using opioids a year later.
  • After 11 days of use, it jumps to 25% of patients still taking opioids a year later.

So it would seem that between 3-5 days, the chances of continued use almost doubled. Then between 5-11 days the chances of use more than doubled. This development may have helped inspire the idea to limit prescriptions to 3 days.

Back in March, Bradley Martin of the CDC, one of the study authors, told Vox magazine:

“There’s nothing magical about five days versus six days, but with each day your risk of dependency increases fairly dramatically,”

So while day 5 and day 6 may not be a dramatic leap over the edge, some may see this proposed limit as an attempt to at least slow a process down.

The Opposing Argument

The Florida Governor will probably face strong criticism, or at least skepticism, from crowds such as:

The opposition is still very real. This isn’t even the first time Florida lawmakers have seen something like this brought to the table. Just last year Florida legislatures quietly rejected an effort last year to impose a five-day cap on opioid prescriptions for acute pain.

Legislatures and doctors are the only concerns Florida Governor may have to tangle with in order to push this idea through. Other potential obstacles standing against this proposal include:

  • Additional out-of-pocket co-pays that patients will incur
  • The ability of patients with chronic pain and terminal illnesses to refill prescriptions

The Florida Society of Interventional Pain Physicians will discuss caps on prescriptions during a board meeting today. Dr. Sanford Silverman is a past president of the Florida Society of Interventional Pain Physicians. In regards to the 3 day limit he stated:

“We don’t think the cap is reasonable since it is a completely arbitrary number,”

“A better idea would be to mandate usage of the PDMP prior to writing an opioid for acute pain.”

Similar Strategies

Other states have created caps on prescriptions, although some may not seem as strict as the 3 day rule.

  • Massachusetts limits the supply to seven days.
  • New Jersey set it so that first-time prescriptions for acute pain cannot exceed a five-day supply. Also, patients being treated for cancer or under hospice care are exempt.
  • Ohio caps distinguish between patients with chronic pain and those with acute pain.

At the end of the day, similar strategies may not be left up to the lawmakers. If pharmacies decide to impose their own limits on certain prescription drugs the Florida Governor might not have to push very hard to get the limits he is looking for.

CVS announced Friday that the company plans to:

  • Limit the daily dosage of pain pills based on their strength
  • Require the use of quick-release painkillers before extended-release opioids are dispensed
  • Limit opioid prescriptions to seven days for certain conditions

This restriction will specifically apply to patients who are new to pain therapy.

Only time will tell how far Florida Governor Rick Scott’s new pitch will go, but it seems one thing people can agree on is that the opioid crisis does require some new approaches to prevention.

With more prevention we may be able to slow down the rising rates of opioid addiction. Meanwhile, the need for safe and effective treatment still means a lot for helping those already suffering. Real treatment resources matter. If you or someone you love is struggling, please call toll-free now. We want to help.

CALL NOW 1-800-951-6135

free treatment ebook

Categories

Accepted Insurance Types Please call to inquire
Call Now